Pakistan: MoUs worth $25million signed as Pharma Asia 2024
Wire desk byline Sourced from Xinhua, Dawn, Arab News, Anadolu and Minute Mirror. Translated and abridged by the GSRRA Desk.
The pharmaceutical Industry is a strength of Pakistan and excelling gradually. Due to excellent quality and competitive prices, the Industry is booming and exporting globally.
The three-day 21st Pharma Asia Exhibition, the premier pharmaceutical exhibition in the region, successfully concluded today at the Expo Centre in Karachi. The event, organized by E-Commerce Gateway, featured Deputy Mayor Karachi, Salman Abdullah Murad, as the chief guest, marking a significant milestone in the evolution of Pakistan’s pharmaceutical industry.
Running from August 20 – 22, Pharma Asia 2024 showcased the latest advancements and innovations, transforming the country’s pharmaceutical landscape. The event attracted over 200 companies and over 750 booths, offering a platform for manufacturers, suppliers, traders, distributors, policymakers, and investors to converge and explore collaboration and business development opportunities.
With participation from 15 countries, including a prominent pavilion from China, the exhibition was a bustling hub of activity and networking. The event provided unparalleled opportunities for international collaboration, making it a key highlight in the global pharmaceutical calendar.
Speaking on the event’s success, Deputy Mayor Karachi Salman Abdullah Murad expressed his appreciation for the enthusiastic participation of both local and international stakeholders. “Pharma Asia 2024 has demonstrated the tremendous potential of our pharmaceutical sector, and the collaboration witnessed here is a testament to the industry’s bright future in Pakistan,” he said.
Dr. Khursheed Nizam, President of E-Commerce Gateway, lauded the overwhelming response from participants. “We are thrilled to witness the enthusiastic participation and engagement from local and international stakeholders. The 21st Pharma Asia Exhibition catalyzes driving innovation and collaboration in Pakistan’s pharma landscape,” he stated. He also appreciated the Pakistan Pharmaceutical Manufacturers’ Association (PPMA) for their unwavering support, acknowledging their critical role in championing industry standards and advocating for advancements.
The growth of Pakistan’s pharmaceutical industry has been further bolstered by the initiatives of the Special Investment Facilitation Council (SIFC), which has created a conducive environment for investment and expansion. The SIFC’s efforts have significantly contributed to the industry’s upward trajectory, attracting local and international investments.
Reference Link:- https://tradechronicle.com/mous-worth-25million-signed-as-pharma-asia-2024/
Zamir Ahmed Awan is the founder and Chair of the Global Silk Route Research Alliance, a think tank in Islamabad. He studied engineering at Shanghai University in the 1980s, and years later he went back to China as Pakistan's science counsellor in Beijing, from 2010 until 2016, working on science and higher education cooperation between the two countries.…
